{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:37:02Z","timestamp":1767962222836,"version":"3.49.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T00:00:00Z","timestamp":1334188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034548","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T21:10:31Z","timestamp":1334265031000},"page":"e34548","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Treatment of Hepatitis C as Prevention: A Modeling Case Study in Vietnam"],"prefix":"10.1371","volume":"7","author":[{"given":"Nicolas","family":"Durier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,4,12]]},"reference":[{"key":"ref1","article-title":"Weekly epidemiological record. No 41, 86, 445\u2013456.","year":"2011"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-\u03b12a and Ribavirin Combination Therapy in Chronic Hepatitis C.","volume":"140","author":"SJ Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1746.2009.05789.x","article-title":"Treatment of chronic hepatitis C in Asia: When East meets West.","volume":"24","author":"ML Yu","year":"2009","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 Infection with Early Antiretroviral Therapy.","volume":"365","author":"MS Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2010.08.029","article-title":"Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility.","volume":"54","author":"NK Martin","year":"2011","journal-title":"Journal of Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2010.03.006","article-title":"Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.","volume":"110","author":"I Zeiler","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jhep.2010.10.033","article-title":"Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.","volume":"55","author":"J Grebely","year":"2011","journal-title":"J Hepatol"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/600304","article-title":"Hepatitis C treatment for injection drug users: a review of the available evidence.","volume":"49","author":"M Hellard","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1440-1746.2010.06238.x","article-title":"Reinfection with hepatitis C virus following sustained virological response in injection drug users.","volume":"25","author":"J Grebely","year":"2010","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1086\/425361","article-title":"Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users.","volume":"39","author":"M Backmund","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000049487","article-title":"Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up.","volume":"8","author":"O Dalgard","year":"2002","journal-title":"Eur Addict Res"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1053\/jhep.2003.50364","article-title":"Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.","volume":"38","author":"GL Davis","year":"2003","journal-title":"Hepatology"},{"key":"ref14","article-title":"Evaluation of the epidemiological impact of harm reduction programs on HIV in Vietnam.","year":"2011"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000390086.14941.91","article-title":"Injection drug use, HIV and the current response in selected low-income and middle-income countries.","volume":"24","author":"AM Bergenstrom","year":"2010","journal-title":"AIDS"},{"key":"ref16","year":"2010"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1360-0443.2001.9634337.x","article-title":"Back-projection estimates of the number of dependent heroin users in Australia.","volume":"96","author":"M Law","year":"2001","journal-title":"Addiction"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/clinids\/11.2.289","article-title":"Needles that kill: modelling human immunodeficiency virus transmission via shared needle injection equipment in shooting galleries.","volume":"11","author":"EH Kaplan","year":"1989","journal-title":"Rev Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/02729890122062659","article-title":"Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users.","volume":"21","author":"HA Pollack","year":"2001","journal-title":"Med Decis Making"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1360-0443.1994.tb00896.x","article-title":"Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors.","volume":"89","author":"P Griffiths","year":"1994","journal-title":"Addiction"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11524-009-9417-9","article-title":"Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.","volume":"87","author":"MC Clatts","year":"2010","journal-title":"J Urban Health"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09540120802017610","article-title":"Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.","volume":"21","author":"VM Quan","year":"2009","journal-title":"AIDS Care"},{"issue":"1\u20133","key":"ref23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2009.01.006","article-title":"Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.","volume":"102","author":"E Roy","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.ede.0000135170.54913.9d","article-title":"Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion.","volume":"15","author":"H Hagan","year":"2004","journal-title":"Epidemiology"},{"key":"ref25","first-page":"332","article-title":"Summary of the major finding from evaluation of the pilot methadone maintenance therapy program in Viet Nam,","author":"TL Nguyen","year":"2010","journal-title":"Journal of practical medicine Vol 742+743"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"AASLD Pratice Guidelines. Diagnosis, Management, and Treatment of Hepatitis C: An Update.","volume":"49","author":"MG Ghany","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2006.01.034","article-title":"Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.","volume":"130","author":"SM Kamal","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"ref28","first-page":"80","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.","volume":"125","author":"JT Gerlach","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.drugpo.2010.10.007","article-title":"Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.","volume":"22","author":"S Corson","year":"2011","journal-title":"Int J Drug Policy"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2036.2008.03834.x","article-title":"Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use.","volume":"29","author":"M Wilkinson","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2893.2008.01041.x","article-title":"A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.","volume":"15","author":"AJ Sutton","year":"2008","journal-title":"Journal of Viral Hepatitis"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"e22309","DOI":"10.1371\/journal.pone.0022309","article-title":"Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users.","volume":"6","author":"NK Martin","year":"2011","journal-title":"PLoS One"},{"issue":"9791","key":"ref33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.","volume":"378","author":"PK Nelson","year":"2011","journal-title":"Lancet"},{"key":"ref34","article-title":"Hepatology. A clinical textbook. Second Edition. Pages 22 and 23.","author":"Mauss","year":"2010"},{"issue":"9635","key":"ref35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(08)61116-2","article-title":"Acute hepatitis C.","volume":"372","author":"A Maheshwari","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.","volume":"13","author":"JM Micallef","year":"2006","journal-title":"J Viral Hepat"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T04:34:30Z","timestamp":1713846870000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034548"}},"subtitle":[],"editor":[{"given":"Golo","family":"Ahlenstiel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,12]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034548","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,12]]}}}